Trials / Conditions / Malignant Peripheral Nerve Sheath Tumors (MPNST)
Malignant Peripheral Nerve Sheath Tumors (MPNST)
3 registered clinical trials studyying Malignant Peripheral Nerve Sheath Tumors (MPNST) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST) NCT04872543 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Active Not Recruiting | A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas NCT03611868 | Ascentage Pharma Group Inc. | Phase 1 / Phase 2 |
| Completed | SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors) NCT02008877 | Sarcoma Alliance for Research through Collaboration | Phase 1 / Phase 2 |